Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
Authors
Keywords
Propensity Score, Propensity Score Match, Cohort Entry, Diabetes Therapy, Medical Surveillance
Journal
DRUG SAFETY
Volume 38, Issue 3, Pages 295-310
Publisher
Springer Nature
Online
2015-03-11
DOI
10.1007/s40264-015-0280-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
- (2014) Elisabetta Patorno et al. DIABETOLOGIA
- Application of marginal structural models in pharmacoepidemiologic studies: a systematic review
- (2014) Shibing Yang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus
- (2013) Christianne L. Roumie et al. ANNALS OF INTERNAL MEDICINE
- Metrics for covariate balance in cohort studies of causal effects
- (2013) Jessica M. Franklin et al. STATISTICS IN MEDICINE
- Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research
- (2013) N. Freemantle et al. BMJ-British Medical Journal
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- (2012) C R Garrett et al. BRITISH JOURNAL OF CANCER
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Effects of Thiazolidinediones on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After Drug-Eluting Stent Implantation: A Retrospective Cohort Study Using the National Health Insurance Database in Taiwan
- (2012) Hsien-Tsung Yeh et al. CLINICAL THERAPEUTICS
- Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
- (2012) Alana Choy-Shan et al. CORONARY ARTERY DISEASE
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis
- (2012) K. M. Pantalone et al. DIABETES OBESITY & METABOLISM
- The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis
- (2012) K. M. Pantalone et al. DIABETIC MEDICINE
- Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
- (2012) A. G. Renehan et al. DIABETOLOGIA
- What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes
- (2012) Christopher Ll. Morgan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
- (2011) X.- X. He et al. ANNALS OF ONCOLOGY
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Beyond the intention-to-treat in comparative effectiveness research
- (2011) Miguel A Hernán et al. Clinical Trials
- Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
- (2011) S. Bo et al. DIABETES OBESITY & METABOLISM
- Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure
- (2011) Charlotte Andersson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- (2011) Jin Ha Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Diabetes Mellitus and Insulin Use on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort
- (2011) Ahmed N. Dehal et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation
- (2011) Tsung-Ming Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study
- (2011) John-Michael Gamble et al. VALUE IN HEALTH
- Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
- (2010) Josie M.M. Evans et al. AMERICAN JOURNAL OF CARDIOLOGY
- Diabetes and risk of bladder cancer
- (2010) Todd MacKenzie et al. CANCER
- Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
- (2010) Casper H Jørgensen et al. Cardiovascular Diabetology
- Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population
- (2010) Debra A. Wertz et al.
- Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the U.K. General Practice Research Database
- (2010) M. R. MacDonald et al. DIABETES CARE
- The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
- (2010) K. M. Pantalone et al. DIABETES CARE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study
- (2010) B. Sillars et al. DIABETES OBESITY & METABOLISM
- Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
- (2010) C. Andersson et al. DIABETOLOGIA
- Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy
- (2010) Giovanni Corrao et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2010) Ronen Loebstein et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan
- (2010) Fei-Yuan Hsiao et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
- (2009) Kevin M. Pantalone et al. ACTA DIABETOLOGICA
- Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients
- (2009) Alain Vanasse et al. Diabetes & Vascular Disease Research
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
- Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
- (2009) Mykola Khalangot et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study
- (2009) Henriette T. Horsdal et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
- (2009) Enrique F. Schisterman et al. EPIDEMIOLOGY
- Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis Patients
- (2009) S. P.B. Ramirez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Second-Generation Sulfonylureas on Survival in Patients With Diabetes Mellitus After Myocardial Infarction
- (2009) Adelaide M. Arruda-Olson et al. MAYO CLINIC PROCEEDINGS
- Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis
- (2009) Zeina A. Habib et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- Effect of Metformin-Containing Antidiabetic Regimens on All-cause Mortality in Veterans With Type 2 Diabetes Mellitus
- (2008) Therese A. Mangold et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy
- (2008) Wolfgang C. Winkelmayer et al. ARCHIVES OF INTERNAL MEDICINE
- Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups
- (2008) Daniel H. Solomon et al. ARTHRITIS AND RHEUMATISM
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
- (2008) Bethany B. Barone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence and Trends of Receipt of Cancer Screenings Among US Women with Diagnosed Diabetes
- (2008) Guixiang Zhao et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More